DE68902755T2 - Antineoplastische formulierungen. - Google Patents

Antineoplastische formulierungen.

Info

Publication number: DE68902755T2
Authority: DE; Germany
Prior art keywords: carboplatin; solution; lyophilisate; reconstituting; antineoplastic
Prior art date: 1988-03-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE8989302599T

Other languages

English (en)

Other versions

DE68902755D1 (de

Inventor

Harold Phillip Levius

Yisrael Geffen

Benjamin Sklarz

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Abic Ltd

Original Assignee

Abic Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-03-20

Filing date

1989-03-16

Publication date

1993-01-14

1989-03-16 Application filed by Abic Ltd filed Critical Abic Ltd

1992-10-15 Publication of DE68902755D1 publication Critical patent/DE68902755D1/de

1993-01-14 Application granted granted Critical

1993-01-14 Publication of DE68902755T2 publication Critical patent/DE68902755T2/de

2009-03-17 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

230000000118 anti-neoplastic effect Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1
190000008236 Carboplatin Chemical compound 0.000 abstract 4
229960004562 carboplatin Drugs 0.000 abstract 4
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
229930195725 Mannitol Natural products 0.000 abstract 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
239000008121 dextrose Substances 0.000 abstract 1
235000010355 mannitol Nutrition 0.000 abstract 1
239000000594 mannitol Substances 0.000 abstract 1
229920005862 polyol Polymers 0.000 abstract 1
150000003077 polyols Chemical class 0.000 abstract 1
239000003755 preservative agent Substances 0.000 abstract 1
230000002335 preservative effect Effects 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DE8989302599T 1988-03-20 1989-03-16 Antineoplastische formulierungen. Expired - Fee Related DE68902755T2 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IL85790A IL85790A0 (en)	1988-03-20	1988-03-20	Solution of carboplatin

Publications (2)

Publication Number	Publication Date
DE68902755D1 DE68902755D1 (de)	1992-10-15
DE68902755T2 true DE68902755T2 (de)	1993-01-14

Family

ID=11058683

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE8989302599T Expired - Fee Related DE68902755T2 (de)	1988-03-20	1989-03-16	Antineoplastische formulierungen.

Country Status (7)

Country	Link
EP (1)	EP0334551B1 (de)
AT (1)	ATE80296T1 (de)
AU (1)	AU623632B2 (de)
DE (1)	DE68902755T2 (de)
ES (1)	ES2044091T3 (de)
IL (1)	IL85790A0 (de)
ZA (1)	ZA891360B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5455270A (en) *	1993-08-11	1995-10-03	Bristol-Myers Squibb Co.	Stabilized solutions of platinum(II) antitumor agents
DE69427595T2 (de) *	1994-02-07	2002-04-25	Pliva Pharmaceutical Industry	Antitumormittel auf basis von carboplatin und herstellung desselben
EP3826613A4 (de) *	2018-08-31	2022-05-04	Sun Pharmaceutical Industries Limited	Parenterale dosierungsform von carboplatin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1119954A (en) *	1978-05-30	1982-03-16	Edmund S. Granatek	Aqueous solution of cisplatin
US4571335A (en) *	1983-06-17	1986-02-18	Taylor Robert C	Method of inhibiting herpetic lesions by the use of platinum coordination compounds

1988
- 1988-03-20 IL IL85790A patent/IL85790A0/xx unknown
1989
- 1989-02-22 ZA ZA891360A patent/ZA891360B/xx unknown
- 1989-02-23 AU AU30265/89A patent/AU623632B2/en not_active Withdrawn - After Issue
- 1989-03-16 EP EP89302599A patent/EP0334551B1/de not_active Expired - Lifetime
- 1989-03-16 DE DE8989302599T patent/DE68902755T2/de not_active Expired - Fee Related
- 1989-03-16 ES ES89302599T patent/ES2044091T3/es not_active Expired - Lifetime
- 1989-03-16 AT AT89302599T patent/ATE80296T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE80296T1 (de)	1992-09-15
AU3026589A (en)	1989-09-21
DE68902755D1 (de)	1992-10-15
ES2044091T3 (es)	1994-01-01
AU623632B2 (en)	1992-05-21
EP0334551A1 (de)	1989-09-27
EP0334551B1 (de)	1992-09-09
ZA891360B (en)	1989-12-27
IL85790A0 (en)	1988-09-30

Legal Events

Date	Code	Title	Description
1993-10-07	8364	No opposition during term of opposition
1994-03-10	8339	Ceased/non-payment of the annual fee

Publication	Publication Date	Title
ES2033429T3 (es)	1993-03-16	Un metodo de preparacion de una composicion farmaceutica.
DE58906847D1 (de)	1994-03-10	Stabilisierte wässrige Lösungen von 3-Isothiazolinonen.
NO894740D0 (no)	1989-11-28	Oftalmisk loesning, samt fremgangsmaate for konservering aven slik loesning.
EP0838221A4 (de)	2003-01-15	Lyophilisierte hgf-zubereitungen
ATE124869T1 (de)	1995-07-15	Stabilisierung von calcitonin enthaltenden pharmazeutischen verbindungen.
DK0666739T3 (da)	2002-04-22	Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
DE68902755D1 (de)	1992-10-15	Antineoplastische formulierungen.
ATE65401T1 (de)	1991-08-15	Stabile, injizierbare loesungen von salzen von vincristin.
ATE92715T1 (de)	1993-08-15	Feste jodophorzusammensetzung.
ATE94070T1 (de)	1993-09-15	Faktor xiii zur vorbeugung von intraventrikulaeren blutungen.
SE8704849D0 (sv)	1987-12-03	Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
NO870941D0 (no)	1987-03-06	Vandige preparater med fytotoksisk virkning.
ES2024503B3 (es)	1992-03-01	Mejoras en, o relacionadas con, el reforzamiento del terreno.
SE8704832L (en)	1989-03-11	Prepn. for dissolving caries - comprises nitrogen-contg. cpds. and sodium hypochlorite
ATE78402T1 (de)	1992-08-15	Waesserige loesungen von doxorubicin.
TH5472EX (th)	1989-01-03	การเตรียมเพพไทด์
TH5472A (th)	1989-01-03	การเตรียมเพพไทด์
FR2269932A1 (en)	1975-12-05	Synergistic hypotensive compsns for oral admin - contg reserpine and guancydine
KR890002182A (ko)	1989-04-08	주사제용 세파만돌 나페이트 제제의 안정화 방법
DK540087A (da)	1988-06-08	Peptidpraeparat